Search
Parkinson's Disease Paid Clinical Trials in Vermont
A listing of 1 Parkinson's Disease clinical trials in Vermont actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 1 of 1
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Parkinson's Disease
Filter by Age
Filter by Type
Gender
Type of Study
Clinical Trial Phase
The state of Vermont currently has 1 active clinical trials seeking participants for Parkinson's Disease research studies. These trials are conducted in various cities, including Burlington, Bennington, Berlin and White River Junction.
Featured Trial
Healthy Participants Needed (Colonoscopy + Cancer Screening)
Recruiting
Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
Conditions:
Healthy
Healthy Volunteers
Healthy Subjects
Healthy Volunteer
Healthy Participants
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Conditions:
Healthy
Healthy Volunteer Study
Featured Offer
Lose 20% of Body Weight With GLP-1's
Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to tirzepatide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.
Semaglutide and Tirzepatide are advanced GLP-1 medications designed to support weight management and metabolic health. They work by targeting GLP-1 receptors in the body, helping regulate appetite, improve blood sugar control, and support sustainable weight loss (up to 22% of body weight).
Get $50 off your first order using promo code: policy-lab-50
Semaglutide and Tirzepatide are advanced GLP-1 medications designed to support weight management and metabolic health. They work by targeting GLP-1 receptors in the body, helping regulate appetite, improve blood sugar control, and support sustainable weight loss (up to 22% of body weight).
Get $50 off your first order using promo code: policy-lab-50
Conditions:
Overweight
Overweight and Obesity
Obesity
Weight Loss
Morbid Obesity
Featured Therapy
Deep Brain Stimulation for Parkinson's Disease Survey
Motor control issues caused by Parkinson’s disease can turn everyday tasks into challenges. When medication alone falls short, another option may offer some relief.
Deep brain stimulation (DBS) may help you experience longer periods of Parkinson's symptom control.†
Take our short survey and see if Medtronic DBS could be an option.
†Tremor, slowed movement, stiffness
Deep brain stimulation (DBS) may help you experience longer periods of Parkinson's symptom control.†
Take our short survey and see if Medtronic DBS could be an option.
†Tremor, slowed movement, stiffness
Conditions:
Parkinson Disease
Parkinson's Disease
Idiopathic Parkinson's Disease
Featured Trial
Buy Retatrutide Online Through Celia
Recruiting
Retatrutide (formerly M25) is an investigational peptide being studied for its potential in supporting weight management and metabolic health. It acts on GLP-1, GIP, and glucagon receptors to influence appetite, energy regulation, and fat metabolism.
Conditions:
Healthy
Featured Trial
COVID-19 Vaccine Clinical Trial (Compensation Provided)
Recruiting
Healthy adults ages 50-64 may qualify. You may be eligible if you haven’t received a COVID-19 vaccine and haven’t had COVID-19 in the last 90 days.
Qualified participants may receive compensation for time and travel.
Qualified participants may receive compensation for time and travel.
Conditions:
Healthy
Pyridostigmine for the Treatment of Constipation in Parkinson Disease
Recruiting
Constipation is a common and debilitating non-motor symptom of Parkinson disease (PD) that often precedes the onset of classic motor symptoms by decades. There is no standardized algorithm for managing constipation in this patient population, nor are there dedicated treatments. Studies suggest that constipation can affect quality of life to a significant degree, in many cases just as much as motor symptoms. There is an unmet need for effective treatment options for constipation in this patient p... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/15/2023
Locations: University of Vermont Medical Center, Burlington, Vermont
Conditions: Parkinson Disease, Constipation
1 - 1 of 1